Examining FDA's Generic Drug and Biosimilar User Fee Programs — Informed

HearingHouse

Examining FDA's Generic Drug and Biosimilar User Fee Programs

Held

Thursday, March 2, 2017

Held by

House Energy and Commerce Committee

Transcript

Transcript (PDF)Transcript (HTML)

Watch / read on Congress.gov

Examining FDA's Generic Drug and Biosimilar User Fee Programs — Informed